Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial

BACKGROUND: COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. At the time this clinical trial was planned, there were no available vaccine or therapeutic agents with proven efficacy, but the severity of the condition prompted...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Trials
Asıl Yazarlar: Diago-Sempere, Elena, Bueno, José Luis, Sancho-López, Aránzazu, Rubio, Elena Múñez, Torres, Ferrán, de Molina, Rosa Malo, Fernández-Cruz, Ana, de Diego, Isabel Salcedo, Velasco-Iglesias, Ana, Payares-Herrera, Concepción, Flecha, Inmaculada Casas, Avendaño-Solà, Cristina, Palomino, Rafael Duarte, Ramos-Martínez, Antonio, Ruiz-Antorán, Belén
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2021
Konular:
Study Protocol
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7816149/
https://ncbi.nlm.nih.gov/pubmed/33472681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-05011-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller